表紙:医薬品有効成分 (API) の市場動向・市場シェア・市場規模の予測 (2021-2028年):合成タイプ (バイオテクノロジー・合成)・製造区分 (自社用・商用)・薬剤区分・用途・地域別
市場調査レポート
商品コード
989728

医薬品有効成分 (API) の市場動向・市場シェア・市場規模の予測 (2021-2028年):合成タイプ (バイオテクノロジー・合成)・製造区分 (自社用・商用)・薬剤区分・用途・地域別

Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 191 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
医薬品有効成分 (API) の市場動向・市場シェア・市場規模の予測 (2021-2028年):合成タイプ (バイオテクノロジー・合成)・製造区分 (自社用・商用)・薬剤区分・用途・地域別
出版日: 2021年02月10日
発行: Grand View Research, Inc.
ページ情報: 英文 191 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医薬品有効成分 (API) の市場規模は予測期間中6.6%のCAGRで推移し、2028年には3125億6000万米ドルの規模に成長すると予測されています。バイオ医薬品部門の成長、API製造の進歩、老齢人口の増加などの要因が同市場の成長を推進する見通しです。

当レポートでは、世界の医薬品有効成分 (API) の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、主なAPIの展望、合成タイプ・製造区分・薬剤区分・用途・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場の見通し
  • 普及・成長の見通しマッピング
  • ユーザーの視点分析
  • 市場力学
  • 市場分析ツール

第4章 API市場:競合分析

  • 主要企業・近年の展開・影響分析
  • 企業の分類
  • ベンダー情勢
  • 公開企業
  • 非公開企業
  • 主な取引・戦略的提携

第5章 APIの展望

  • 売上高の推移
  • 企業の位置付け:API別
    • アモキシシリン
    • アジスロマイシン
    • ブレオマイシン
    • カスポファンギン
    • クラリスロマイシン
    • クラブラン酸
    • クリンダマイシン
    • コンパクチン(メバスタチン)
    • シクロスポリン
    • ダクチノマイシン
    • ダプトマイシン
    • デメクロサイクリン
    • ドキシサイクリン
    • エリスロマイシン
    • イベルメクチン(アベルメクチン)
    • ロバスタチン
    • ミカファンギン
    • ミノサイクリン
    • マイトマイシン
    • ミコフェノール酸
    • ニューモカンジンB0
    • ポリミキシン
    • プラバスタチン
    • ラパマイシン(シロリムス)
    • シンバスタチン
    • ステロイド
    • タクロリムス
    • テトラサイクリン
    • チゲサイクリン
    • トブラマイシン
    • バンコマイシン
  • 価格の比較分析

第6章 市場予測・動向分析:合成タイプ別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • バイオテックAPI
  • モノクローナル抗体
  • 組換えタンパク質
  • ワクチン
  • 合成API

第7章 市場予測・動向分析:製造区分別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 自社用
  • 商用

第8章 市場予測・動向分析:タイプ別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • ジェネリック薬
  • 先発薬

第9章 市場予測・動向分析:用途別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 循環器疾患
  • 腫瘍
  • 中枢神経系と神経内科
  • 整形外科
  • 内分泌学
  • 呼吸器内科
  • 消化器内科
  • 腎臓内科
  • 眼科
  • その他

第10章 市場予測・動向分析:地域・主要国別

  • ダッシュボード
  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • SWOT分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第11章 企業プロファイル

  • AbbVie, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Cipla, Inc.
  • Merck & Co., Inc.
  • Albemarle Corporation
  • Aurobindo Pharma
  • Viatris Inc. (Mylan N.V.)
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
図表

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Regulatory Framework
  • TABLE 4 Global Active Pharmaceutical Ingredients Market, By Region, 2017 - 2028 (USD Billion)
  • TABLE 5 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 6 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 7 Global Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 8 Global Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 9 North America Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 10 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 11 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 12 North America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 13 North America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 15 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 16 U.S. Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 17 U.S. Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 22 Europe Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 23 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 24 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 25 Europe Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 26 Europe Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 27 U.K. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 28 U.K. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 29 U.K. Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 30 U.K. Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 31 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 32 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 33 Germany America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 34 Germany America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 35 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 36 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 37 France Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 38 France Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 39 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 40 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 41 Spain Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 42 Spain Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 43 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 44 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 45 Italy Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 46 Italy Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 47 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 48 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 49 Russia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 50 Russia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 51 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 52 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 53 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 54 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 55 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 56 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 57 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 58 China Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 59 China Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 60 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 61 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 62 Japan Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 63 Japan Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 64 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 65 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 66 India Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 67 India Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 68 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 69 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 70 South Korea Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 71 South Korea Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 72 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 73 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 74 Australia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 75 Australia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 76 Latin America Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 77 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 78 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 79 Latin America Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 80 Latin America Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 81 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 82 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 83 Brazil Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 84 Brazil Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 85 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 86 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 87 Mexico Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 88 Mexico Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 89 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 90 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 91 Argentina Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 92 Argentina Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 93 MEA Active Pharmaceutical Ingredients Market, By Country, 2017 - 2028 (USD Billion)
  • TABLE 94 MEA Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 95 MEA Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 96 MEA Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 97 MEA Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 98 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 99 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 100 South Africa Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 101 South Africa Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 102 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 103 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 104 UAE Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 105 UAE Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)
  • TABLE 106 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2017 - 2028 (USD Billion)
  • TABLE 107 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2017 - 2028 (USD Billion)
  • TABLE 108 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2017 - 2028 (USD Billion)
  • TABLE 109 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028 (USD Billion)

List of Figures

  • FIG. 1 API market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 API market, segment outlook
  • FIG. 10 API market, competitive outlook
  • FIG. 11 API market outlook (2020)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 User perspective analysis
  • FIG. 14 Market driver relevance analysis (Current & future impact)
  • FIG. 15 Global percentage of the population, by age group, 2050 and 2000
  • FIG. 16 Market restraint relevance analysis (Current & future impact)
  • FIG. 17 Porter's five forces analysis
  • FIG. 18 PESTLE analysis
  • FIG. 19 Ansoff Matrix
  • FIG. 20 Heat map analysis
  • FIG. 21 Company market position analysis
  • FIG. 22 Company market position analysis
  • FIG. 23 Market differentiators
  • FIG. 24 Strategy mapping
  • FIG. 25 API market: Type of synthesis movement analysis
  • FIG. 26 Segment dashboard
  • FIG. 27 API market type of synthesis outlook: Key takeaways
  • FIG. 28 Biotech API market, 2017 - 2028 (USD Billion)
  • FIG. 29 Monoclonal antibodies market, 2017 - 2028 (USD Billion)
  • FIG. 30 Recombinant proteins market, 2017 - 2028 (USD Billion)
  • FIG. 31 Vaccines market, 2017 - 2028 (USD Billion)
  • FIG. 32 Synthetic API market, 2017 - 2028 (USD Billion)
  • FIG. 33 API market: Type of manufacturers movement analysis
  • FIG. 34 Segment dashboard
  • FIG. 35 API market type of manufacturers outlook: Key takeaways
  • FIG. 36 Captive API market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 37 Merchant API market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 38 API market: Type movement analysis
  • FIG. 39 Segment dashboard
  • FIG. 40 API market type outlook: Key takeaways
  • FIG. 41 Generic APIs market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 42 Innovative APIs market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 43 API market: Application movement analysis
  • FIG. 44 Segment dashboard
  • FIG. 45 API market application outlook: Key takeaways
  • FIG. 46 Cardiovascular diseases market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 47 Oncology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 48 CNS & neurology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 49 Orthopedics market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 50 Endocrinology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 51 Pulmonology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 52 Gastroenterology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 53 Nephrology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 54 Ophthalmology market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 55 Others market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 56 Regional outlook, 2020 & 2028
  • FIG. 57 Regional market dashboard
  • FIG. 58 Regional market place: Key takeaways
  • FIG. 59 North America, SWOT Analysis
  • FIG. 60 Europe, SWOT Analysis
  • FIG. 61 Asia Pacific, SWOT Analysis
  • FIG. 62 Latin America, SWOT Analysis
  • FIG. 63 MEA, SWOT Analysis
  • FIG. 64 North America
  • FIG. 65 North America market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 66 U.S.
  • FIG. 67 U.S. market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 68 Canada
  • FIG. 69 Canada market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 70 Europe
  • FIG. 71 Europe market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 72 U.K.
  • FIG. 73 U.K. market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 74 Germany
  • FIG. 75 Germany market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 76 Spain
  • FIG. 77 Spain market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 78 France
  • FIG. 79 France market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 80 Italy
  • FIG. 81 Italy market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 82 Russia
  • FIG. 83 Russia market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 84 Asia Pacific
  • FIG. 85 Asia Pacific market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 86 Japan
  • FIG. 87 Japan market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 88 China
  • FIG. 89 China market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 90 India
  • FIG. 91 India market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 92 South Korea
  • FIG. 93 South Korea market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 94 Australia
  • FIG. 95 Australia market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 96 Latin America
  • FIG. 97 Latin America market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 98 Brazil
  • FIG. 99 Brazil market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 100 Mexico
  • FIG. 101 Mexico market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 102 Argentina
  • FIG. 103 Argentina market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 104 MEA
  • FIG. 105 MEA market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 106 South Africa
  • FIG. 107 South Africa market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 108 Saudi Arabia
  • FIG. 109 Saudi Arabia market estimates and forecast, 2017 - 2028 (USD Billion)
  • FIG. 110 UAE
  • FIG. 111 UAE market estimates and forecast, 2017 - 2028 (USD Billion)
目次
Product Code: GVR-1-68038-348-5

Active Pharmaceutical Ingredient Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like "Make in India".

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Active Pharmaceutical Ingredient Market Report Highlights

  • According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
  • The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
  • According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
  • Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
  • Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Regional scope
    • 1.1.2 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 Key KoL Responses
  • 1.9 Market share calculations
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations
  • 1.12 Objectives
    • 1.12.1 Objective 1
    • 1.12.2 Objective 2
    • 1.12.3 Objective 3
    • 1.12.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Segment Outlook
  • 2.2 Competitive Outlook
  • 2.3 Market Outlook

Chapter 3 API Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
  • 3.2 Penetration and Growth Prospect Mapping
  • 3.3 User Perspective Analysis
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Growing geriatric population
      • 3.4.1.2 Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
      • 3.4.1.3 Increasing preference for targeted therapy approach in cancer treatment
      • 3.4.1.4 Increasing preference for outsourcing APIs
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 High capital investments and production cost
      • 3.4.2.2 Stringent Safety and handling regulations regarding APIs
  • 3.5 Market Analysis Tools
    • 3.5.1 Industry Analysis: Porter's
    • 3.5.2 PESTLE Analysis
    • 3.5.3 Regulatory Scenario

Chapter 4 API Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 4.1.1 Ansoff matrix
    • 4.1.2 Heat map analysis
  • 4.2 Company Categorization
    • 4.2.1 Innovators
    • 4.2.2 Market Leaders
  • 4.3 Vendor Landscape
    • 4.3.1 List of key distributors and channel partners
    • 4.3.2 Key customers
    • 4.3.3 Key company market share analysis, 2020
  • 4.4 Public Companies
    • 4.4.1 Company market position analysis
    • 4.4.2 Company market position analysis
    • 4.4.3 Competitive Dashboard Analysis
      • 4.4.3.1 Market Differentiators
  • 4.5 Private Companies
    • 4.5.1 List of key emerging companies
  • 4.6 Major Deals and Strategic Alliances Analysis
    • 4.6.1 Joint Ventures
    • 4.6.2 Acquisitions
    • 4.6.3 Licensing and Partnerships
    • 4.6.4 Technological Collaborations

Chapter 5 API Molecules Outlook

  • 5.1 Global Sales of API Molecules, USD Million, 2017 - 2020
  • 5.2 Companies with the leading market position for API molecules
    • 5.2.1 Amoxicillin
    • 5.2.2 Azithromycin
    • 5.2.3 Bleomycin
    • 5.2.4 Caspofungin
    • 5.2.5 Clarithromycin
    • 5.2.6 Clavulanic acid
    • 5.2.7 Clindamycin
    • 5.2.8 Compactin (Mevastatin)
    • 5.2.9 Cyclosporin
    • 5.2.10 Dactinomycin
    • 5.2.11 Daptomycin
    • 5.2.12 Demeclocycline
    • 5.2.13 Doxycycline
    • 5.2.14 Erythromycin
    • 5.2.15 Ivermectin (Avermectin)
    • 5.2.16 Lovastatin
    • 5.2.17 Micafungin
    • 5.2.18 Minocycline
    • 5.2.19 Mitomycin
    • 5.2.20 Mycophenolic acid
    • 5.2.21 Pneumocandin B0
    • 5.2.22 Polymyxin
    • 5.2.23 Pravastatin
    • 5.2.24 Rapamycin (Sirolimus)
    • 5.2.25 Simvastatin
    • 5.2.26 Steroids
    • 5.2.27 Tacrolimus
    • 5.2.28 Tetracycline
    • 5.2.29 Tigecycline
    • 5.2.30 Tobramycin
    • 5.2.31 Vancomycin
  • 5.3 Comparative price analysis of the above-mentioned molecules

Chapter 6 API Market: Segment Analysis, by Type of Synthesis, 2017 - 2028 (USD Billion)

  • 6.1 Definition and Scope
  • 6.2 Type of Synthesis Market Share Analysis, 2020 & 2028
  • 6.3 Segment Dashboard
  • 6.4 Global API Market, by Type of Synthesis, 2017 to 2028
  • 6.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 6.5.1 Biotech API
      • 6.5.1.1 Biotech API market, 2017 - 2028 (USD Billion)
    • 6.5.2 Monoclonal Antibodies
      • 6.5.2.1 Monoclonal antibodies market, 2017 - 2028 (USD Billion)
    • 6.5.3 Recombinant Proteins
      • 6.5.3.1 Recombinant proteins market, 2017 - 2028 (USD Billion)
    • 6.5.4 Vaccines
      • 6.5.4.1 Vaccines market, 2017 - 2028 (USD Billion)
    • 6.5.5 Synthetic API
      • 6.5.5.1 Synthetic API market, 2017 - 2028 (USD Billion)

Chapter 7 API Market: Segment Analysis, by Type of Manufacturer, 2017 - 2028 (USD Billion)

  • 7.1 Definition and Scope
  • 7.2 Type of Manufacturer Market Share Analysis, 2020 & 2028
  • 7.3 Segment Dashboard
  • 7.4 Global API Market, by Type of Manufacturers, 2017 to 2028
  • 7.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 7.5.1 Captive API
      • 7.5.1.1 Captive API market, 2017 - 2028 (USD Billion)
    • 7.5.2 Merchant API
      • 7.5.2.1 Captive API market, 2017 - 2028 (USD Billion)

Chapter 8 API Market: Segment Analysis, by Type, 2017 - 2028 (USD Billion)

  • 8.1 Definition and Scope
  • 8.2 Type Market Share Analysis, 2020 & 2028
  • 8.3 Segment Dashboard
  • 8.4 Global API Market, by Type, 2017 to 2028
  • 8.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 8.5.1 Generic APIS
      • 8.5.1.1 Generic APIs market, 2017 - 2028 (USD Billion)
    • 8.5.2 Innovative APIs
      • 8.5.2.1 Innovative APIS market, 2017 - 2028 (USD Billion)

Chapter 9 API Market: Segment Analysis, by Application, 2017 - 2028 (USD Billion)

  • 9.1 Definition and Scope
  • 9.2 Application Market Share Analysis, 2020 & 2028
  • 9.3 Segment Dashboard
  • 9.4 Global API Market, by Application, 2017 to 2028
  • 9.5 Market Size & Forecasts and Trend Analyses, 2017 to 2028
    • 9.5.1 Cardiovascular Diseases
      • 9.5.1.1 Cardiovascular diseases market, 2017 - 2028 (USD Billion)
    • 9.5.2 Oncology
      • 9.5.2.1 Oncology market, 2017 - 2028 (USD Billion)
    • 9.5.3 CNS and Neurology
      • 9.5.3.1 CNS and neurology market, 2017 - 2028 (USD Billion)
    • 9.5.4 Orthopedics
      • 9.5.4.1 Orthopedics market, 2017 - 2028 (USD Billion)
    • 9.5.5 Endocrinology
      • 9.5.5.1 Endocrinology market, 2017 - 2028 (USD Billion)
    • 9.5.6 Pulmonology
      • 9.5.6.1 Pulmonology market, 2017 - 2028 (USD Billion)
    • 9.5.7 Gastroenterology
      • 9.5.7.1 Gastroenterology market, 2017 - 2028 (USD Billion)
    • 9.5.8 Nephrology
      • 9.5.8.1 Nephrology market, 2017 - 2028 (USD Billion)
    • 9.5.9 Ophthalmology
      • 9.5.9.1 Ophthalmology market, 2017 - 2028 (USD Billion)
    • 9.5.10 Others
      • 9.5.10.1 Others market, 2017 - 2028 (USD Billion)

Chapter 10 API Market: Regional Market Analysis, 2017 - 2028 (USD Billion)

  • 10.1 Definition & Scope
  • 10.2 Regional Market Share Analysis, 2020 & 2028
  • 10.3 Regional Market Dashboard
  • 10.4 Regional Market Snapshot
  • 10.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 10.5.1 North America
    • 10.5.2 Europe
    • 10.5.3 Asia Pacific
    • 10.5.4 Latin America
    • 10.5.5 MEA
  • 10.6 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
  • 10.7 North America
    • 10.7.1 North America Market estimates and forecast, 2017 - 2028 (USD Billion)
    • 10.7.2 U.S.
      • 10.7.2.1 U.S. API market, 2017 - 2028 (USD Billion)
    • 10.7.3 Canada
      • 10.7.3.1 Canada API market, 2017 - 2028 (USD Billion)
  • 10.8 Europe
    • 10.8.1 Europe API market, 2017 - 2028 (USD Billion)
    • 10.8.2 U.K.
      • 10.8.2.1 U.K. API market, 2017 - 2028 (USD Billion)
    • 10.8.3 Germany
      • 10.8.3.1 Germany API market, 2017 - 2028 (USD Billion)
    • 10.8.4 Spain
      • 10.8.4.1 Spain API market, 2017 - 2028 (USD Billion)
    • 10.8.5 France
      • 10.8.5.1 France API market, 2017 - 2028 (USD Billion)
    • 10.8.6 Italy
      • 10.8.6.1 Italy API market, 2017 - 2028 (USD Billion)
    • 10.8.7 Russia
      • 10.8.7.1 Russia API market, 2017 - 2028 (USD Billion)
  • 10.9 Asia Pacific
    • 10.9.1 Asia Pacific API market, 2017 - 2028 (USD Billion)
    • 10.9.2 Japan
      • 10.9.2.1 Japan API market, 2017 - 2028 (USD Billion)
    • 10.9.3 China
      • 10.9.3.1 China API market, 2017 - 2028 (USD Billion)
    • 10.9.4 India
      • 10.9.4.1 India API market, 2017 - 2028 (USD Billion)
    • 10.9.5 South Korea
      • 10.9.5.1 South Korea API market, 2017 - 2028 (USD Billion)
    • 10.9.6 Australia
      • 10.9.6.1 Australia API market, 2017 - 2028 (USD Billion)
  • 10.10 Latin America
    • 10.10.1 Latin America API Market, 2017 - 2028 (USD Billion)
    • 10.10.2 Brazil
      • 10.10.2.1 Brazil API market, 2017 - 2028 (USD Billion)
    • 10.10.3 Mexico
      • 10.10.3.1 Mexico API market, 2017 - 2028 (USD Billion)
    • 10.10.4 Argentina
      • 10.10.4.1 Argentina API market, 2017 - 2028 (USD Billion)
  • 10.11 MEA
    • 10.11.1 MEA API market, 2017 - 2028 (USD Billion)
    • 10.11.2 South Africa
      • 10.11.2.1 South Africa API market, 2017 - 2028 (USD Billion)
    • 10.11.3 Saudi Arabia
      • 10.11.3.1 Saudi Arabia API market, 2017 - 2028 (USD Billion)
    • 10.11.4 UAE
      • 10.11.4.1 UAE API market, 2017 - 2028 (USD Billion)

Chapter 11 Company Profiles

  • 11.1 AbbVie, Inc.
    • 11.1.1 Company overview
    • 11.1.2 Financial performance
    • 11.1.3 Product benchmarking
    • 11.1.4 Strategic initiatives
  • 11.2 Boehringer Ingelheim International GmbH
    • 11.2.1 Company overview
    • 11.2.2 Financial performance
    • 11.2.3 Product benchmarking
    • 11.2.4 Strategic initiatives
  • 11.3 Bristol-Myers Squibb Company
    • 11.3.1 Company overview
    • 11.3.2 Financial performance
    • 11.3.3 Product benchmarking
    • 11.3.4 Strategic initiatives
  • 11.4 Cipla, Inc.
    • 11.4.1 Company overview
    • 11.4.2 Financial performance
    • 11.4.3 Product benchmarking
    • 11.4.4 Strategic initiatives
  • 11.5 Merck & Co., Inc.
    • 11.5.1 Company overview
    • 11.5.2 Financial performance
    • 11.5.3 Product benchmarking
    • 11.5.4 Strategic initiatives
  • 11.6 Albemarle Corporation
    • 11.6.1 Company overview
    • 11.6.2 Financial performance
    • 11.6.3 Product benchmarking
  • 11.7 Aurobindo Pharma
    • 11.7.1 Company overview
    • 11.7.2 Financial performance
    • 11.7.3 Product benchmarking
    • 11.7.4 Strategic initiatives
  • 11.8 Viatris Inc. (Mylan N.V.)
    • 11.8.1 Company overview
    • 11.8.2 Financial performance
    • 11.8.3 Product benchmarking
    • 11.8.4 Strategic initiatives
  • 11.9 Teva Pharmaceutical Industries Ltd.
    • 11.9.1 Company overview
    • 11.9.2 Financial performance
    • 11.9.3 Product benchmarking
    • 11.9.4 Strategic initiatives
  • 11.10 Sun Pharmaceutical Industries Ltd.
    • 11.10.1 Company overview
    • 11.10.2 Financial performance
    • 11.10.3 Product benchmarking
    • 11.10.4 Strategic initiatives
  • 11.11 Dr. Reddy's Laboratories Ltd.
    • 11.11.1 Company overview
    • 11.11.2 Financial performance
    • 11.11.3 Product benchmarking
    • 11.11.4 Strategic initiatives